IOE administration ameliorates insulin resistance and hyperglycemia in db/db mice, probably through activation of the IRS/PI3K/Akt pathway and an increase in GLUT4 expression in muscle and WAT. The gene discussed is SLC2A4; the disease is Hyperglycemia.